Application of Artemisia argyi essential oil as a TRPA1 pathway inhibitor in anti-inflammatory and antipruritic drugs
By using volatile oil of wormwood as a TRPA1 pathway inhibitor, the shortcomings of the TRPA1 pathway in the prior art were solved, and effective anti-inflammatory and anti-itching effects on allergic contact dermatitis were achieved, which significantly reduced the spontaneous scratching and epidermis in ACD mice. Thickening inhibits inflammatory cell infiltration and exerts anti-inflammatory and anti-itching effects by inhibiting the phosphorylation of key proteins.
Patent Information
- Application Number
- CN202211668460.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-12-23
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2042-12-23
AI Technical Summary
There is a lack of effective TRPA1 pathway inhibitors in the prior art for the treatment of allergic contact dermatitis, especially in the suppression of inflammatory pain and neuralgia, and there is a lack of research on allergic contact dermatitis.
Variety oil from mugwort is used as a TRPA1 pathway inhibitor, and volatile oil is extracted from mugwort by Soxhlet extraction, and TNF-α, IL-1β, IL-6, IL-33 and IL- 4 expression reduces spontaneous scratching and epidermal thickening, achieving anti-inflammatory and anti-itchi effects.
Varied oil in mugwort significantly alleviates spontaneous scratching and epidermal thickening in ACD mice, inhibits inflammatory cell infiltration, and effectively exerts anti-inflammatory and anti-itching effects by inhibiting the phosphorylation of key proteins.
Smart Images

Figure BDA0004015396340000041 
Figure BDA0004015396340000051 
Figure BDA0004015396340000081
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of traditional Chinese medicines, and in particular to application of wormwood leaf volatile oil as a TRPA1 pathway inhibitor in anti-inflammatory and antipruritic drugs. Background Art
[0002] In recent years, with the new environmental pollution brought about by industrial development, the problem of air pollution PM2.5 has intensified. Coupled with the influence of lifestyle, the probability of various allergens inducing immune allergic reactions such as dust mites, pollen, pet hair, food additives, etc. is getting higher and higher. The incidence of allergic problems such as atopic dermatitis / eczema, allergic asthma, allergic rhinitis, allergic dermatitis, sensitive skin, etc. has increased accordingly, attracting attention from all parties.
[0003] Artemisia argyi is the dried leaves of Artemisia argyi Levl.et Vant., a plant of the Asteraceae family. It has the effects of warming the meridians and stopping bleeding, dispelling cold and relieving pain, and removing dampness and relieving itching for external use. Studies have found that Artemisia argyi mainly contains chemical components such as volatile oils, flavonoids, organic acids and triterpenes, and has pharmacological effects such as bactericidal, anti-inflammatory, analgesic, antioxidant, and anti-tumor. Artemisia argyi volatile oil is the main active ingredient of Artemisia argyi, which has pharmacological effects such as relieving asthma, expectorant, antitussive, antibacterial, and antiallergic. Modern research has also proved that Artemisia argyi volatile oil has anti-inflammatory effects, and can reduce the expression of inflammatory factors such as IL-1β and TNF-α in a variety of different inflammatory diseases such as acute ear swelling, foot edema, and arthritis.
[0004] Allergic contact dermatitis is a type IV or delayed hypersensitivity reaction mediated by allergen-specific T cells and is divided into two main stages. The first stage is sensitization when a person is first exposed to an allergen. Allergens are haptens, which are defined as low molecular weight antigens that can trigger an immune response when combined with a larger carrier. Initially, haptens are phagocytosed by Langerhans cells or dermal dendritic cells, and the hapten-peptide complexes migrate to the local lymph nodes of the skin, where they trigger hapten-specific T cells Th1, Th2, Th17 and T regulatory cells that proliferate and circulate in the blood, and naive T cells that specifically recognize the major T cell compatibility complex molecule complex of allergens will expand and become effector T cells and memory T cells. The next stage is stimulation, where re-exposure to the allergen leads to recognition by the now sensitive hapten-specific T cells, causing an inflammatory cascade of cytokines and cell infiltration, thereby producing the clinical symptoms of chronic allergic contact dermatitis (ACD).
[0005] Transient receptor potential ankyrin 1 (TRPA1) ion channel is a member of the transient receptor potential ion channel family and an important molecule that mediates pain signal transduction. Selective inhibition of TRPA1 has an inhibitory effect on inflammatory pain, visceral pain, neuralgia, etc. Highly specific antagonists of TRPA1 have been developed, and their pharmacological effects have also been verified in animal models of inflammatory pain, visceral pain, neuralgia, etc. However, there are few reports on the effects of TRPA1 antagonists on animal models of allergic contact dermatitis.
[0006] The Squaric acid di-n-butyl ester (SADBE) model is a small molecule hapten that is commonly used to treat alopecia areata and has been used as a popular ACD inducer in mice. In recent years, many studies have explored the neuroimmune mechanism of chronic itch caused by SADBE. Transient receptor potential (TRP) channels in immune cells in the epithelium and skin expressing TRPV4, sensory neurons expressing TRPV1 and TRPA1, or TRPV4 are the molecular and cellular basis of chronic itch induced by SADBE. Summary of the invention
[0007] In view of the deficiencies in the prior art, the present invention aims to provide an application of wormwood volatile oil as a TRPA1 pathway inhibitor in the preparation of anti-inflammatory and antipruritic drugs.
[0008] Furthermore, the volatile oil of Artemisia argyi is used in the preparation of medicines for treating allergic contact dermatitis.
[0009] Furthermore, the allergic contact dermatitis is induced by dibutyl squarate.
[0010] Furthermore, the drug achieves anti-inflammatory effects by downregulating MAPK and JAK / STAT3 signaling pathways.
[0011] Furthermore, the drug achieves anti-inflammatory effect by inhibiting the expression of cytokines TNF-α, IL-1β, IL-6, IL-33 and IL-4.
[0012] Furthermore, the drug achieves anti-inflammatory effect by inhibiting the expression of p-p38, p-ERK1 / 2 and p-STAT3 proteins.
[0013] Furthermore, the drug achieves an antipruritic effect by alleviating spontaneous scratching, epidermal thickening and inflammatory cell infiltration.
[0014] Furthermore, the preparation method of the wormwood leaf volatile oil is as follows: using wormwood leaf as raw material, water as solvent, adopting Soxhlet extraction method to prepare, collecting volatile oil from the extractor, and drying to obtain the volatile oil.
[0015] Furthermore, the mugwort leaf is Artemisia argyi.
[0016] Compared with the prior art, the present invention has the following advantages and beneficial effects:
[0017] (1) The volatile oil of Artemisia argyi provided by the present invention has anti-inflammatory and antipruritic uses and can significantly reduce spontaneous scratching, epidermal thickening and inflammatory cell infiltration in ACD mice.
[0018] (2) The wormwood volatile oil provided by the present invention can downregulate the MAPK and JAK / STAT3 signaling pathways, inhibit the expression levels of inflammatory cytokines such as TNF-α, IL-1β, IL-6, IL-33 and IL-4, and inhibit the expression of p-p38, p-ERK1 / 2 and p-STAT3 proteins, thereby achieving anti-inflammatory and antipruritic effects. The anti-inflammatory and antipruritic effects of the wormwood volatile oil were verified in the SADBE-induced mouse allergic contact dermatitis itch model. BRIEF DESCRIPTION OF THE DRAWINGS
[0019] Figure 1 In the figure, A represents the GC-MS spectrum of the mixed reference substance of six main components, and B represents the GC-MS spectrum of the Qi Ai volatile oil sample.
[0020] Figure 2 This is a whole-cell patch clamp assay.
[0021] Figure 3 A is a calcium imaging test image of wild-type mouse DRG, and B is a TRPA1 knockout mouse DRG imaging test image.
[0022] Figure 4 In the figure, A is the SADBE modeling diagram, and B is the effect of Qi Ai volatile oil on the number of times mice scratch in the ACD model.
[0023] Figure 5 This is the effect of Qi Ai volatile oil on the pathological changes of the skin of ACD mice. A is the H&E staining of skin tissue, B is the toluidine blue staining of skin tissue, C is the statistical result of H&E staining, and D is the statistical result of toluidine blue staining.
[0024] Figure 6 This is the effect of Qi Ai volatile oil on the mRNA expression level of inflammatory factors in the skin tissue of ACD mice.
[0025] Figure 7 The phosphorylation levels of ERK1 / 2, p38 and STAT3 in the skin tissue of ACD mice were affected by Qi Ai volatile oil. A is a protein graph, and B, C, and D are the statistical results of p-ERK1 / 2, p-p38, and p-STAT3, respectively.
[0026] Figure 3-6All data are expressed as mean ± SEM. Graph Pad Prism 6 software was used for statistical analysis and drawing, and one-way ANOVA was used for data comparison. p < 0.05 was considered statistically significant. Compared with the normal group, # P<0.05, ## P<0.01, ### P<0.001; compared with the model group, * P<0.05, ** P<0.01, *** P<0.001. DETAILED DESCRIPTION
[0027] To facilitate those skilled in the art to understand the contents of the present invention, the applicant further describes the technical solutions of the present invention in conjunction with specific embodiments below, but the following content should not limit the scope of protection requested by the claims of the present invention in any form.
[0028] Example 1. Extraction of Artemisia argyi volatile oil
[0029] Weigh 200 g of naturally dried mugwort leaves from Qichun County, Hubei Province, crush them appropriately, put them in a 5000 mL round-bottom flask, add 2400 mL of water and soak them for 2 h. Turn on the fire and boil, then adjust the heat to medium to keep it boiling slightly. Stop heating after 6 h, let it stand for a while, collect the volatile oil from the Soxhlet extractor, and then dry it over anhydrous sodium sulfate to obtain 1.5256 g of Qi Artemisia argyi volatile oil.
[0030] Example 2. Determination of the content of volatile oil in Artemisia argyi
[0031] 2.1 Preparation of reference solution
[0032] Accurately measure 127.90 mg of eucalyptol, 112.00 mg of (-)-α-thujone, 110.30 mg of (+)-camphor, 108.80 mg of (+)-borneol, 143.30 mg of 4-terpineol, and 115.00 mg of β-caryophyllene, and add them to a 5 mL volumetric flask, and dilute to the mark with chromatographically pure methanol to prepare a stock solution. Take 1.00 mL of eucalyptol stock solution, 1.00 mL of (-)-α-thujone stock solution, 1.00 mL of (+)-camphor stock solution, 0.50 mL of (+)-borneol stock solution, 0.25 mL of 4-terpineol stock solution, and 0.25 mL of β-caryophyllene stock solution, and dilute to the mark with methanol (chromatographically pure) in a 5 mL volumetric flask (mixed standard 1), and dilute mixed standard 1 to 2 times, 10 times, 20 times, and 100 times with methanol, respectively.
[0033] 2.2 GC-MS analysis conditions
[0034] Chromatographic column: DB-5 (30m×0.32mm×0.25μm), inlet: 280℃ (split ratio 5:1), column oven: 60℃ for 1 minute, increase the temperature to 250℃ at 10℃ / min and hold for 1min, detector: FID280℃, carrier gas: high-purity helium, flow rate: 1.0mL / min.
[0035] 2.3 Mass spectrometry (MS) experimental conditions:
[0036] The energy source is: EI source, electron energy is 70ev, and the temperature is 250℃.
[0037] According to the GC-MS results, the contents of caryophyllene, terpineol, thujone, eucalyptol, camphor and borneol in the volatile oil of Artemisia argyi are relatively high. Figure 1 The contents of the six main components are shown in Table 1.
[0038] Table 1 GC-MS analysis results of the main components of Qi Ai volatile oil
[0039]
[0040]
[0041] Example 3. Whole-cell patch clamp
[0042] The present invention uses whole-cell patch clamp to detect the effect of Qi Ai volatile oil (referred to as QA) on HEK293T cells transiently transfected with hTRPA1. HEK239T cells laid on coverslips are transferred to a glass dish with extracellular fluid, and whole-cell patch clamp recording is performed at room temperature using an EPC 10 (HEK Elektronik) amplifier and an inverted microscope stage equipped with a GFP visualization filter. A silicate glass pipette containing 140mMCsCl, 10mMEGTA, 10mM hepes, 2mMMg-ATP (pH 7.3 and 315mOsm / lin osmotic pressure) solution with a resistance of 2-4 megohms is used, and whole-cell patch clamp recording is performed using an extracellular solution containing 140mMNaCl, 5mM KCl, 2mM MgCl2, 10mM HEPES and 10mM D-Glucose (pH7.4 and 340mOsm / lin osmotic pressure). Whole-cell membrane currents were recorded using a voltage ramp from -60 to +60 mV at a holding potential of 0 mV for 500 ms. Clampfit10 (Molecular Devices) was used for data analysis and plotting.
[0043] The results are as follows Figure 2As shown, the co-administration of 80 μg / ml of the Qi Ai volatile oil prepared in Example 1 (the volatile oil was first prepared into a mother solution with DMSO and diluted to the required concentration with extracellular fluid when used) and the hTRPA1 agonist (30 μM AITC) hardly caused changes in the hTRPA1 channel current. After washing with the buffer (extracellular fluid), the hTRPA1 channel was still activated by the administration of 30 μM AITC alone again. This result shows that Qi Ai volatile oil has a significant inhibitory effect on the hTRPA1 channel.
[0044] Example 4. Calcium imaging
[0045] DRG neurons were seeded on coated slides. After 12 h, they were placed in a Ca-free medium containing 4 μM Fura-2AM (Shanghai, China) and 0.01% F-127. 2+ / Mg 2+ The cells were placed in HBSS solution and placed in the dark for 30 minutes. They were washed with a solution containing 145 mM sodium chloride, 5 mM potassium chloride, 2 mM calcium chloride, 1 mM magnesium sulfate, 10 mM HEPES, 10 mM glucose, pH 7.4. The concentration of intracellular free calcium was observed by imaging the cells at 340 and 380 nm excitation waves. The transfected cells were stimulated with AITC (10 μM) (Sigma-Aldrich, Shanghai, China), which produced a significant increase in intracellular calcium ions ([Ca 2+ ] i ) changes, and then washed to the baseline level. After QA (referring to the Qi Ai volatile oil prepared in Example 1, the same below, no further description) was given for 0.5 minutes, AITC was given for 0.5 minutes at the same time, and then QA at different concentrations (40, 80 μg / ml) was continuously given for 0.5 minutes and then washed. AITC was given again until the baseline was given positive drugs, and then stopped after washing. [Ca 2+ ] i We further extracted DRG neurons from wild-type C57BL / 6 mice and TRPA1 knockout mice and used calcium imaging to examine whether QA also has an inhibitory effect on mTRPA1 channels.
[0046] The results are as follows Figure 3 As shown in A, both low and high doses (40 and 80 μg / ml) of QA could significantly inhibit the [Ca 2+ ] i HC-030031 is a potent and selective TRPA1 channel inhibitor. The results showed that 40 μM HC-030031 completely inhibited the activation of TRPA1 channels on wild-type mouse DRG by 10 μM AITC. Figure 3After TRPA1 was knocked out, AITC could not be activated as shown in B. In summary, QA can also significantly inhibit TRPA1 channels on mouse neurons, and this effect disappears after the TRPA1 gene is ablated.
[0047] Example 5. Behavioral Experiment
[0048] 5.1 Preparation of Qi Ai Ointment
[0049] The low, medium and high dose concentrations of 15% (15 μL / 100 μL), 30% (30 μL / 100 μL) and 60% (60 μL / 100 μL) of Qi Ai volatile oil ointment were prepared respectively. The steps are as follows: accurately measure 150 μL, 300 μL and 600 μL of Qi Ai volatile oil prepared in Example 1 (the weight of each 100 μL of Qi Ai volatile oil is 93.25 mg), then add propylene glycol to make the volume to 1 mL, vortex mix and centrifuge at low speed for short time, and use it immediately after preparation.
[0050] 5.2 Experimental methods
[0051] After one week of adaptive breeding in an SPF laboratory, C57BL / 6 mice of appropriate age were modeled with acetone-di-n-butyl squarate (SADBE) to establish the mouse ACD model. The specific steps are as follows: three days before the modeling, the hair on the abdomen and neck of the mice was shaved, and the area range was 1.5cm×1.5cm. On the fourth day, the modeling began, and the mixture of SADBE and acetone (1:200) was evenly applied to the shaved area of the abdomen at a dose of 20μL / mouse, and waited for about 30s for it to be fully absorbed; once a day (9 am) for 3 consecutive days. From the 4th to the 8th day after the modeling began, the mice rested, and the mice were placed in the behavioral observation box at 9 am every day to adapt for about 1.5h. From the 9th to the 11th day of the modeling, the mixture of SADBE and acetone (1:200) was evenly applied to the shaved area of the neck at a dose of 20μL / mouse, and waited for about 30s for it to be fully absorbed. 0.5h after the modeling on the 11th day, all mice were videotaped for about 1.5h to record behavioral data. After completing the statistics of behavioral data, the mice with successful modeling were randomly divided into 6 cages: normal group (NC, 8 mice), model group (SADBE, 8 mice), low-dose group (QA-L, 8 mice), medium-dose group (QA-M, 8 mice), high-dose group (QA-H, 8 mice), and positive drug group (HC, 8 mice). From the 12th to the 15th day of modeling, the drug solution was given to the drug group at 9 am every day. The drug solution was evenly applied to the shaved part of the mouse neck at 100 μL / mouse, and waited for 1min for its absorption. 0.5h after administration, the video was recorded for about 1.5h, and the behavioral data were recorded.
[0052] The results are as follows Figure 4As shown in B, compared with the blank group, the number of scratching in the ACD mice induced by SADBE increased significantly from day 12 to day 15. In the ACD mice treated with the Qi Ai volatile oil prepared in Example 1, the number of scratching showed a downward trend, and there was a significant difference in statistics. The behavioral results showed that Qi Ai volatile oil could inhibit the itching caused by SADBE.
[0053] Example 6. H&E staining and toluidine blue staining
[0054] Cut the mouse neck skin tissue to a size of about 1cm x 1.5cm, fix it in 4% paraformaldehyde for 12 hours, then dehydrate it with 20% and 25% sugar solution gradient, embed it in paraffin and dewax it, put the slices in xylene I and xylene II for 10min each, then add anhydrous ethanol I and anhydrous ethanol II for 5min each, soak in ethanol gradient, 95v / v%, 90v / v%, 80v / v%, 70v / v% each concentration for 5min, and finally wash it with distilled water. Then stain the slices in hematoxylin for 5min, wash with tap water, differentiate with 1% hydrochloric acid alcohol for a few seconds, and rinse with tap water. Then immerse the slices in eosin stain and toluidine blue stain (toluidine blue stain 1:100) for 2min. Then, the slices were placed in 95% alcohol I and 95% alcohol II for 5 min each, anhydrous ethanol I and anhydrous ethanol II for 5 min each, xylene I and xylene II for 5 min each, dehydrated and transparent, and finally the slices were taken out of xylene to dry slightly and sealed with neutral gum. Microscope examination, image acquisition and analysis ( Figure 5 A and 5B). Each slice was randomly photographed in 5-8 different fields of view, and then the skin thickness and number of mast cells at 5-8 different locations in each field of view were measured to obtain the average value. Finally, the average value of the skin thickness of each mouse was calculated as the statistical result.
[0055] The statistical results are as follows Figure 5 C and 5D. Compared with the blank control group, the neck skin of the SADBE model group showed obvious epidermal hyperplasia. Compared with the model group, the skin thickness of the group treated with Qi Ai volatile oil and hydrocortisone butyrate cream (HC group) was significantly reduced and the related inflammatory cell infiltration was reduced. The average number of mast cells in the SADBE model group was significantly increased compared with the blank control group, while the number of mast cells was significantly reduced after intervention with Qi Ai volatile oil and hydrocortisone butyrate cream (HC).
[0056] Example 7. Effect of the Qi Ai volatile oil prepared in Example 1 on inflammatory factors in skin tissue
[0057] The separated mouse neck skin tissue was placed in a 2mL centrifuge tube. 1ml of Trizol reagent and two 3mm zirconium beads were added to each tube. The tube was placed in a homogenizer base and homogenized rapidly at 65Hz for 90s to fully grind the tissue. The lysate was centrifuged at 12000rpm for 5min at 4℃. The supernatant was carefully transferred to a new 1.5mL centrifuge tube and 1 / 5 volume of chloroform was added to the lysate. The tube was tightly capped and vortexed for 15s. The emulsion was shaken into an emulsion and allowed to stand for 5min. The emulsion was centrifuged at 12000rpm for 15min at 4℃. Carefully remove the centrifuge tube, carefully pipette the upper aqueous phase into a new 1.5mL centrifuge tube, add an equal volume of isopropanol, mix by inverting, and let stand at room temperature for 10min. Then centrifuge at 12000rpm for 10min at 4℃. Carefully remove the supernatant, add 1 mL of 75 v / v% ethanol prepared with DEPC water and anhydrous ethanol, thoroughly wash the tube cap and tube wall, and flick the bottom of the tube to suspend the precipitate, and let it stand for 5 minutes. Centrifuge at 7500 rpm for 5 minutes at 4 ° C, discard the supernatant, dry the precipitate at room temperature in a clean environment for 5 minutes, add 30 μL of RNase-free water to dissolve the precipitate, vortex for 15 seconds, and use an ultra-micro detection plate to detect the mRNA concentration of each sample. Use a reverse transcription kit, according to the instructions, reverse the extracted RNA into cDNA, and perform real-time fluorescence quantitative PCR (q-PCR), and perform standard operations according to the instructions. The results were standardized using β-Actin as a reference gene, and the primer sequences are shown in Table 2.
[0058] Table 2 Primer sequences for detecting cytokine genes
[0059]
[0060] The present invention detected the mRNA expression level of TRPA1 in the neck skin of mice. The results showed that the mRNA level of TRPA1 was significantly higher in the SADBE group than in the NC group. It was significantly reduced after the application of Qi Ai volatile oil and hydrocortisone butyrate cream. In addition, the present invention also detected the mRNA expression level of related inflammatory mediators (TNF-α, IL-6, IL-1β, IL-33 and IL-4) in the neck skin of mice. The results are as follows Figure 6 As shown in the figure, compared with the NC group, the mRNA levels of the above inflammatory mediators in the skin of mice in the SADBE group were increased. After local treatment with Qi Ai volatile oil and hydrocortisone butyrate cream, the increase in the mRNA levels of the above inflammatory factors in the skin of mice was significantly reversed. These results show that Qi Ai volatile oil can significantly reduce the mRNA expression level of TRPA1 channels related to itch in the skin of ACD mice and improve the immune cell aggregation of ACD diseases, indicating that Qi Ai volatile oil can play an anti-inflammatory role by inhibiting the production of inflammatory mediators.
[0061] Example 8. Western blot
[0062] Prepare SDS-PAGE gel according to the recipe in the gel preparation kit instructions. After the lower gel is prepared, place it at room temperature for 1 hour to solidify before preparing the upper gel. Put the upper gel into the gel preparation plate and insert the comb. After the gel is completely solidified at room temperature, transfer the gel to the electrophoresis tank, add electrophoresis solution to cover the gel surface by about 1 cm, and carefully pull out the comb. Start loading the sample, point the markers on both sides of the sample, and add protein loading buffer (1×) to the excess holes. During electrophoresis, the voltage of the upper concentrated gel is a constant voltage of 80V, and the time is about 1h. When the colored bands of the marker begin to separate, it means that the separation gel layer has been reached. At this time, adjust the voltage to 100V, and stop electrophoresis when the blue band of the bottom layer reaches the bottom of the glass plate. Soak the PVDF membrane in methanol for 5 minutes before use, and then use a transfer instrument for semi-dry transfer at 20V for 20 minutes. After the transfer is completed, rinse the PVDF membrane in TBST for 5 minutes, and then block it with 6% BSA solution for one hour. After the blocking is completed, according to the molecular weight of the target protein, the relevant target bands are cut at the appropriate position of the membrane, and the primary antibody is applied at 4°C overnight. The primary antibodies used include anti-β-TubuLin, p-ERK1 / 2, ERK1 / 2, p-p38, p38, STAT3, and p-STAT3. On the second day, the primary antibody is first recovered, and then the membrane is washed five times with TBST on a shaker, each time for 7 minutes, and the secondary antibody is matched in the interval between washing the membrane. The secondary antibody is divided into mouse antibody and rabbit antibody. β-TubuLin is applied with mouse antibody (1:10000), and other target bands are applied with rabbit antibody (1:20000). The membrane is incubated in the secondary antibody for 60 minutes at room temperature. After the secondary antibody is applied, the membrane is washed 5 times with TBST, each time for 7 minutes. Finally, the protein bands are visualized using ECL developer, the protein abundance is detected under the chemiluminometer, and the gray value is semi-quantitatively analyzed using an imaging system.
[0063] This question was explored by Western Blot. Figure 7 As shown in the figure, compared with the NC group, the levels of p-ERK1 / 2, p-p38 and p-STAT3 in the skin of mice in the SADBE group were significantly increased. The phosphorylation levels of ERK1 / 2, p38 and STAT3 in the skin of mice were significantly decreased after the application of Qi Ai volatile oil and hydrocortisone butyrate cream. This shows that Qi Ai volatile oil can play an anti-inflammatory role by inhibiting the activation of key enzymes such as ERK1 / 2, p38 and STAT3 in MAPK and JAK / STAT3, and attenuate the inflammatory response of ACD mice.
[0064] in conclusion
[0065] In summary, the Qi Ai volatile oil provided by the present invention has anti-inflammatory and antipruritic effects. It can inhibit the hTRPA1 current activated by AITC and significantly inhibit the TRPA1 channel on mouse neurons, and this effect disappears after the TRPA1 gene is ablated. Topical application can reduce spontaneous scratching, epidermal thickening and inflammatory cell infiltration in ACD mice. At the same time, it also inhibits the mRNA expression of TRPA1 in the skin; and reduces the production of proinflammatory cytokines such as TNF-α, IL-1β, IL-6, IL-33 and IL-4 in the skin. In addition, Qi Ai volatile oil treatment can also reduce the phosphorylated protein expression levels of ERK1 / 2, p38 and STAT3 in ACD mice. By inhibiting the increase of inflammatory factors in the skin, the activation of MAPK and JAK / STAT3 inflammatory pathways exerts anti-inflammatory and antipruritic effects.
Claims
1. The use of volatile oil of Artemisia argyi in the preparation of a drug for treating allergic contact dermatitis, characterized in that: The preparation method of the wormwood leaf volatile oil comprises the following steps: weighing naturally dried wormwood leaves from Qichun County, Hubei Province, crushing them appropriately, placing them in a round-bottom flask, adding water at a liquid-solid ratio of 12 mL:1 g, soaking them for 2 hours, boiling them over a fire, adjusting the fire to medium and keeping them slightly boiling, stopping heating after 6 hours, standing them for a while, collecting the volatile oil from a Soxhlet extractor, and then drying them over anhydrous sodium sulfate to obtain the wormwood leaf volatile oil; The obtained volatile oil of Artemisia argyi contains caryophyllene, terpineol, thujone, eucalyptol, camphor and borneol, and their contents are 5.09%, 12.06%, 11.64%, 17.22%, 3.03% and 2.71% respectively.
2. The use according to claim 1, characterized in that: The drug achieves an antipruritic effect by alleviating spontaneous scratching, epidermal thickening and inflammatory cell infiltration.
3. The use according to claim 1, characterized in that: The medicine is a liniment.
